Sandeep Kulkarni, M.D., has over two decades of experience in the life sciences ecosystem, as a physician, investor, and biotech entrepreneur. He is a co-founder of Zura Bio and serves as its Chief Executive Officer. Prior to Zura, Dr. Kulkarni was the co founder of Tourmaline Bio, where he led the company as Chief Executive Officer from September 2021 through its acquisition by Novartis, which closed in October 2025. Earlier in his career, Dr. Kulkarni held multiple roles at Roivant Sciences from July 2018 to June 2020, including Chief Operating Officer of Immunovant, Inc., Vice President of Special Projects, and Ombudsman to the Investment Committee. Prior to Roivant, he was an Investment Analyst on the life sciences team at QVT Financial LP. Dr. Kulkarni earned a Bachelor of Arts in Economics from Harvard College and a Doctor of Medicine from the University of California, San Francisco.